(en) Katoh S, « Sepiapterin Reductase from Horse Liver: Purification and Properties of the Enzyme. », Arch. Biochem. Biophys., vol. 146, no 1, , p. 202–214 (PMID4401291, DOI10.1016/S0003-9861(71)80057-7)
(en) Matsubara M, Katoh S, Akino M, Kaufman S, « Sepiapterin Reductase. », Biochim. Biophys. Acta., vol. 122, no 2, , p. 202–212 (PMID5969298, DOI10.1016/0926-6593(66)90062-2)
(en) Takikawa S, Curtius HC, Redweik U, Walter Leimbacher et Sandro Ghisla, « Biosynthesis of tetrahydrobiopterin. Purification and characterization of 6-pyruvoyl-tetrahydropterin synthase from human liver », Eur. J. Biochem., vol. 161, no 2, , p. 295–302 (PMID3536512, DOI10.1111/j.1432-1033.1986.tb10446.x)
(en) Thöny B, Heizmann CW, Mattei MG, « Human GTP-cyclohydrolase I gene and sepiapterin reductase gene map to region 14q21-q22 and 2p14-p12, respectively, by in situ hybridization », Genomics, vol. 26, no 1, , p. 168–170 (PMID7782081, DOI10.1016/0888-7543(95)80101-Q)
(en) Maruyama K, Sugano S, « Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides », Gene, vol. 138, nos 1–2, , p. 171–174 (PMID8125298, DOI10.1016/0378-1119(94)90802-8)
(en) Maier J, Schott K, Werner T, A Bacher et I Ziegler, « Northern blot analysis of sepiapterin reductase mRNA in mammalian cell lines and tissues », Adv. Exp. Med. Biol., vol. 338, , p. 195–8 (PMID8304109, DOI10.1007/978-1-4615-2960-6_39)
(en) Maier J, Schott K, Werner T, A Bacher et I Ziegler, « Detection of a novel sepiapterin reductase mRNA: assay of mRNA in various cells and tissues of various species », Exp. Cell Res., vol. 204, no 2, , p. 217–222 (PMID8440319, DOI10.1006/excr.1993.1027)
(en) Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, A Suyama et S Sugano, « Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library », Gene, vol. 200, nos 1–2, , p. 149–156 (PMID9373149, DOI10.1016/S0378-1119(97)00411-3)
(en) Blau N, Thöny B, Renneberg A, L. A. Arnold et K. Hyland, « Dihydropteridine reductase deficiency localized to the central nervous system », J. Inherit. Metab. Dis., vol. 21, no 4, , p. 433–434 (PMID9700606, DOI10.1023/A:1005327313348)
(en) Ohye T, Hori TA, Katoh S, T Nagatsu et H Ichinose, « Genomic organization and chromosomal localization of the human sepiapterin reductase gene », Biochem. Biophys. Res. Commun., vol. 251, no 2, , p. 597–602 (PMID9792819, DOI10.1006/bbrc.1998.9503)
(en) Blau N, Thöny B, Renneberg A, J. M. Penzien, K. Hyland et G. F. Hoffmann, « Variant of dihydropteridine reductase deficiency without hyperphenylalaninaemia: effect of oral phenylalanine loading », J. Inherit. Metab. Dis., vol. 22, no 3, , p. 216–220 (PMID10384371, DOI10.1023/A:1005584627797)
(en) Bonafé L, Thöny B, Penzien JM, Barbara Czarnecki et Nenad Blau, « Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia », Am. J. Hum. Genet., vol. 69, no 2, , p. 269–277 (PMID11443547, PMCID1235302, DOI10.1086/321970)
(en) Fujimoto K, Takahashi SY, Katoh S, « Mutational analysis of sites in sepiapterin reductase phosphorylated by Ca2+/calmodulin-dependent protein kinase II », Biochim. Biophys. Acta, vol. 1594, no 1, , p. 191–8 (PMID11825621, DOI10.1016/S0167-4838(01)00300-4)
(en) Strausberg RL, Feingold EA, Grouse LH, JG Derge, RD Klausner, FS Collins, L Wagner, CM Shenmen et GD Schuler, « Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences », Proc. Natl. Acad. Sci. U.S.A., vol. 99, no 26, , p. 16899–16903 (PMID12477932, PMCID139241, DOI10.1073/pnas.242603899)
(en) Franscini N, Bachli EB, Blau N, M Fischler, RB Walter, A Schaffner et G Schoedon, « Functional tetrahydrobiopterin synthesis in human platelets », Circulation, vol. 110, no 2, , p. 186–192 (PMID15197144, DOI10.1161/01.CIR.0000134281.82972.57)
(en) Steinberger D, Blau N, Goriuonov D, Juliane Bitsch, Michael Zuker, Sibylla Hummel et Ulrich Müller, « Heterozygous mutation in 5'-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia », Neurogenetics, vol. 5, no 3, , p. 187–190 (PMID15241655, DOI10.1007/s10048-004-0182-3)
(en) Gerhard DS, Wagner L, Feingold EA, CM Shenmen, LH Grouse, G Schuler, SL Klein, S Old et R Rasooly, « The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC) », Genome Res., vol. 14, no 10B, , p. 2121–2127 (PMID15489334, PMCID528928, DOI10.1101/gr.2596504)
(en) Sharma M, Mueller JC, Zimprich A, P Lichtner, A Hofer, P Leitner, S Maass, D Berg et A Dürr, « The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations », J. Med. Genet., vol. 43, no 7, , p. 557–562 (PMID16443856, PMCID2593029, DOI10.1136/jmg.2005.039149)
(en) Farrugia R, Scerri CA, Montalto SA, Raymond Parascandolo, Brian G.R. Neville et Alex E. Felice, « Molecular genetics of tetrahydrobiopterin (BH4) deficiency in the Maltese population », Mol. Genet. Metab., vol. 90, no 3, , p. 277–283 (PMID17188538, DOI10.1016/j.ymgme.2006.10.013)
(en) Tobin JE, Cui J, Wilk JB, J Latourelle, J Laramie, A McKee, M Guttman, S Karamohamed et A Destefano, « Sepiapterin reductase expression is increased in Parkinson's disease brain tissue », Brain Res., vol. 1139, , p. 42–47 (PMID17270157, PMCID1868471, DOI10.1016/j.brainres.2007.01.001)